This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, Oxford Biomedical Research, AbD Serotec
product type :
antibody
product name :
RABBIT ANTI RAT INTERLEUKIN-4:Biotin
catalog :
AAR16B
quantity :
50 µg
price :
423 USD
clonality :
polyclonal
host :
rabbit
conjugate :
biotin
reactivity :
rat
application :
western blot, ELISA
product information
EntityType :
Polyclonal Antibody
EntityCategory :
Antibodies
ProductCode :
AAR16B
Description :
RABBIT ANTI RAT INTERLEUKIN-4:Biotin
Specificity :
IL-4
TargetSpecies :
Rat
Host :
Rabbit
Format :
Biotin
Isotypes :
Polyclonal IgG
Applications :
E, WB
ApplicationTypes :
ELISA, Western Blotting
Quantity :
50 µg
QuantityValue :
50
QuantityType :
µg
PriceGBP :
299
PriceEUR :
423
PriceUSD :
423 USD
GOAccessions :
GO:0002674, GO:0002677, GO:0005125, GO:0005136, GO:0005615, GO:0006954, GO:0006955, GO:0007565, GO:0007584, GO:0008083, GO:0042493, GO:0010155, GO:0014070, GO:0032733, GO:0034097, GO:0042113, GO:0043193, GO:0045019, GO:0045471, GO:0071288
GOTerms :
activation of gene-specific transcription, activation of interleukin-10 production, autocrine activity, B lymphocyte activation, B-cell activation, B-lymphocyte activation, carrying of young, cellular response to mercuric ion, cellular response to mercury, down regulation of acute inflammatory response, down regulation of chronic inflammatory response, down regulation of nitric oxide biosynthetic process, downregulation of acute inflammatory response, down-regulation of acute inflammatory response, downregulation of chronic inflammatory response, down-regulation of chronic inflammatory response, downregulation of nitric oxide biosynthetic process, down-regulation of nitric oxide biosynthetic process, drug resistance, drug susceptibility/resistance, gestation, GO:0017035, GO:0017036, IL-4, inhibition of acute inflammatory response, inhibition of chronic inflammatory response, inhibition of nitric oxide biosynthetic process, intercellular space, interleukin-4 receptor ligand, negative regulation of nitric oxide anabolism, negative regulation of nitric oxide biosynthesis, negative regulation of nitric oxide formation, negative regulation of nitric oxide synthesis, nutritional response pathway, paracrine activity, positive regulation of IL-10 production, response to nutrients, response to organic cyclic substance, stimulation of gene-specific transcription, stimulation of interleukin-10 production, up regulation of gene-specific transcription, up regulation of interleukin-10 production, up-regulation of gene-specific transcription, upregulation of gene-specific transcription, up-regulation of interleukin-10 production, upregulation of interleukin-10 production
UniprotAccessions :
P20096
Gene :
Il4
GeneID URL :
www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=287287
EntityFormats :
Purified, Biotin
UNSPSC :
12352203
Concentration :
IgG concentration 0.1mg/ml after reconstitution.
ProductForm :
Purified IgG conjugated to Biotin - lyophilised
PrimarySecondary :
Primary
PriceCHF :
495
PriceSEK :
4217
PriceNOK :
4189
PriceDKK :
3149
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.